<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2021-34-49-59</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-2349</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group></article-categories><title-group><article-title>Пограничные состояния в дерматоонкологии</article-title><trans-title-group xml:lang="en"><trans-title>Borderline conditions in dermato-oncology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7045-4636</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селезнев</surname><given-names>С. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Seleznev</surname><given-names>S. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Селезнев Сергей Павлович, врач-онколог</p><p>Москва</p><p> </p></bio><bio xml:lang="en"><p>Seleznev Sergei P., oncologist</p><p>Moscow</p></bio><email xlink:type="simple">selezserpavl@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3261-6718</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тамразова</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Tamrazova</surname><given-names>O. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тамразова Ольга Борисовна, д. м. н., проф. кафедры дерматовенерологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Tamrazova Olga B., DM Sci (habil.), professor at Dept of Dermatovenereology</p><p>Moscow</p></bio><email xlink:type="simple">anait_tamrazova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8487-137X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергеев</surname><given-names>В. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergeev</surname><given-names>V. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергеев Василий Юрьевич, к. м. н., доцент кафедры дерматовенерологии и косметологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Sergeev Vasiliy Yu., PhD Med, associate professor at Dept of Dermatovenereology and Cosmetology</p><p>Moscow</p></bio><email xlink:type="simple">vasesergeevu@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4349-3023</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитаев</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitaev</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитаев Валентин Григорьевич, д. т. н., проф., зав. кафедрой компьютерных медицинских систем</p><p>Москва</p></bio><bio xml:lang="en"><p>Nikitaev Valentin G., Dr Tech Sci (habil.), professor, head of Dept of Computer Medical Systems</p><p>Moscow</p></bio><email xlink:type="simple">VGNikitayev@mephi.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0443-8504</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Проничев</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Pronichev</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проничев Александр Николаевич, к. т. н., доцент отделения биотехнологий офиса образовательных программ</p><p>Москва</p></bio><bio xml:lang="en"><p>Pronichev Alexander N., PhD Tech, associate professor at Dept of Biotechnology of the Office of Educational Programs</p><p>Moscow</p></bio><email xlink:type="simple">anpronichev@mephi.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ МО «Московский областной научно-исследовательский клинический институт имени М. Ф. Владимирского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Regional Research Clinical Institute n. a. M. F. Vladimirsky</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГАОУ ВО «Национальный исследовательский ядерный университет „МИФИ“»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2021</year></pub-date><volume>0</volume><issue>34</issue><issue-title>Дерматология (3)</issue-title><fpage>49</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Селезнев С.П., Тамразова О.Б., Сергеев В.Ю., Никитаев В.Г., Проничев А.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Селезнев С.П., Тамразова О.Б., Сергеев В.Ю., Никитаев В.Г., Проничев А.Н.</copyright-holder><copyright-holder xml:lang="en">Seleznev S.P., Tamrazova O.B., Sergeev V.Y., Nikitaev V.G., Pronichev A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/2349">https://www.med-alphabet.com/jour/article/view/2349</self-uri><abstract><p>В данной обзорной статье представлены общие сведения об этиологии, патогенезе, клинической картине, диагностике, а также методах лечения таких заболеваний, как актинический кератоз, кератоакантома и болезнь Боуэна. Подробно описаны провоцирующие факторы, вызывающие данные нозологии, где основное значение придается инсоляции, предшествующей иммуносупрессии и иммунодефицитным состояниям, а также травматизации. Патогенез данных заболеваний описан в виде каскадных моделей. Представлены различные клинические формы и их основные дерматоскопические признаки, пригодные для цифровой обработки в автоматизированных диагностических системах. Описан ступенчатый подход в лечении данных нозологий, а также оценивается предварительный прогноз на основе длительности прогрессирования и вероятности трансформации в плоскоклеточный рак кожи. Учитывая тот факт, что дерматоонкологи до сих не пришли к единому мнению о классификации описанных заболеваний, в данной статье они рассматриваются как пограничные, демонстрируя тем самым тонкую грань перехода из предракового состояния в рак in situ.</p></abstract><trans-abstract xml:lang="en"><p>This review article provides an overview of the etiology, pathogenesis, clinical presentation, diagnosis, and treatment methods for actinic keratosis, keratoacanthoma, and Bowen’s disease. The provoking factors are described, where the main importance is attached to insolation, previous immunosuppression and immunodeficiency and trauma. The pathogenesis of these diseases is described in the form of cascade models. Various clinical forms and their main dermatoscopic features, suitable for digital processing in automated diagnostic systems, are presented. A stepwise approach to the treatment of these nosologies is described, and a preliminary prognosis is assessed based on the duration of progression and the likelihood of transformation into squamous cell carcinoma. Given the fact that dermato-oncologists have not yet come to a consensus on the classification of the described diseases, in this article they are considered as a borderline, thereby demonstrating a fine line of transition from a precancerous state to cancer in situ.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>актинический кератоз</kwd><kwd>кератоакантома</kwd><kwd>болезнь Боуэна</kwd><kwd>рак in situ</kwd><kwd>плоскоклеточный рак кожи</kwd><kwd>дерматоскопия</kwd><kwd>цифровая обработка изображений</kwd></kwd-group><kwd-group xml:lang="en"><kwd>actinic keratosis</kwd><kwd>keratoacanthoma</kwd><kwd>Bowen’s disease</kwd><kwd>cancer in situ</kwd><kwd>squamous cell carcinoma</kwd><kwd>dermatoscopy</kwd><kwd>digital imaging analysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке РНФ по проекту № 19–11–00176.</funding-statement><funding-statement xml:lang="en">This work was supported by the Russian Science Foundation under Project No. 19–11–00176.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Waldman A., &amp; Schmults C. (2019). Cutaneous Squamous Cell Carcinoma. Hematology. Oncology Clinics of North America, 33 pp 1–2.</mixed-citation><mixed-citation xml:lang="en">Waldman A., &amp; Schmults C. (2019). Cutaneous Squamous Cell Carcinoma. Hematology. Oncology Clinics of North America, 33 pp 1–2.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson A. K., Kelley B. F., Prokop L J., Murad M. H., &amp; Baum C. L. (2016). Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death. JAMA Dermatology, 152 (4), 419. DOI: 10.1001/jamadermatol.2015.4994.</mixed-citation><mixed-citation xml:lang="en">Thompson A. K., Kelley B. F., Prokop L J., Murad M. H., &amp; Baum C. L. (2016). Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death. JAMA Dermatology, 152 (4), 419. DOI: 10.1001/jamadermatol.2015.4994.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">WHO Classification of Tumours, 4th Edition, Volume 11. Edited by Elder DE, Massi D, Scolyer RA, Willemze R. 2018.</mixed-citation><mixed-citation xml:lang="en">WHO Classification of Tumours, 4th Edition, Volume 11. Edited by Elder DE, Massi D, Scolyer RA, Willemze R. 2018.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kirby JS, Scharnitz T, Seiverling EV, Ahrns H, Ferguson S. Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality. Dermatol Res Pract. 2015; 2015: 456071. DOI: 10.1155/2015/456071.</mixed-citation><mixed-citation xml:lang="en">Kirby JS, Scharnitz T, Seiverling EV, Ahrns H, Ferguson S. Actinic Keratosis Clinical Practice Guidelines: An Appraisal of Quality. Dermatol Res Pract. 2015; 2015: 456071. DOI: 10.1155/2015/456071.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol. 2012 May-Jun; 87 (3): 425–34. DOI: 10.1590/s0365–05962012000300012. PMID: 22714759.</mixed-citation><mixed-citation xml:lang="en">Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol. 2012 May-Jun; 87 (3): 425–34. DOI: 10.1590/s0365–05962012000300012. PMID: 22714759.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol. 2000 Jul; 43 (1 Pt 1): 138–50. DOI: 10.1067/mjd.2000.107497. PMID: 10863242.</mixed-citation><mixed-citation xml:lang="en">Heaphy MR Jr, Ackerman AB. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol. 2000 Jul; 43 (1 Pt 1): 138–50. DOI: 10.1067/mjd.2000.107497. PMID: 10863242.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma («actinic keratosis»). J Am Acad Dermatol. 2000 Jan; 42 (1 Pt 2): 11–7. DOI: 10.1067/mjd.2000.103344. PMID: 10607351.</mixed-citation><mixed-citation xml:lang="en">Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma («actinic keratosis»). J Am Acad Dermatol. 2000 Jan; 42 (1 Pt 2): 11–7. DOI: 10.1067/mjd.2000.103344. PMID: 10607351.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ishioka P., Marques S. A., Hirai A. T., Marques M. E.A., Hirata S. H., &amp; Yamada S. (2009). Prevalence of precancerous skin lesions and non-melanoma skin cancer in Japanese-Brazilians in Bauru, São Paulo State, Brazil. Cadernos de Saúde Pública, 25 (5), 965–971. DOI: 10.1590/s0102–311x2009000500003.</mixed-citation><mixed-citation xml:lang="en">Ishioka P., Marques S. A., Hirai A. T., Marques M. E.A., Hirata S. H., &amp; Yamada S. (2009). Prevalence of precancerous skin lesions and non-melanoma skin cancer in Japanese-Brazilians in Bauru, São Paulo State, Brazil. Cadernos de Saúde Pública, 25 (5), 965–971. DOI: 10.1590/s0102–311x2009000500003.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">R. Lucas, A. Prüss-Üstün, World Health Organization Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation World Health Organization, Public Health and the Environment, Geneva 2006.</mixed-citation><mixed-citation xml:lang="en">R. Lucas, A. Prüss-Üstün, World Health Organization Solar ultraviolet radiation: global burden of disease from solar ultraviolet radiation World Health Organization, Public Health and the Environment, Geneva 2006.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fargnoli MC, Altomare G, Benati E, Borgia F et. all. Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics. Eur J Dermatol. 2017 Dec 1; 27 (6): 599–608. English. DOI: 10.1684/ejd.2017.3126. PMID: 29311040.</mixed-citation><mixed-citation xml:lang="en">Fargnoli MC, Altomare G, Benati E, Borgia F et. all. Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics. Eur J Dermatol. 2017 Dec 1; 27 (6): 599–608. English. DOI: 10.1684/ejd.2017.3126. PMID: 29311040.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Schaefer I, Augustin M, Spehr C, Reusch M, Kornek T. Prevalence and risk factors of actinic keratoses in Germany – analysis of multisource data. J Eur Acad Dermatol Venereol. 2014 Mar; 28 (3): 309–13. DOI: 10.1111/jdv.12102. Epub 2013 Jan 24. PMID: 23347271.</mixed-citation><mixed-citation xml:lang="en">Schaefer I, Augustin M, Spehr C, Reusch M, Kornek T. Prevalence and risk factors of actinic keratoses in Germany – analysis of multisource data. J Eur Acad Dermatol Venereol. 2014 Mar; 28 (3): 309–13. DOI: 10.1111/jdv.12102. Epub 2013 Jan 24. PMID: 23347271.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Naldi L, Chatenoud L, Piccitto R, Colombo P, Placchesi EB, La Vecchia C; Prevalence of Actinic Keratoses Italian Study (PraKtis) Group. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: Results from the Prevalence of Actinic Keratoses Italian Study, 2003–2004. Arch Dermatol. 2006 Jun; 142 (6): 722–6. DOI: 10.1001/archderm.142.6.722. PMID: 16785374.</mixed-citation><mixed-citation xml:lang="en">Naldi L, Chatenoud L, Piccitto R, Colombo P, Placchesi EB, La Vecchia C; Prevalence of Actinic Keratoses Italian Study (PraKtis) Group. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: Results from the Prevalence of Actinic Keratoses Italian Study, 2003–2004. Arch Dermatol. 2006 Jun; 142 (6): 722–6. DOI: 10.1001/archderm.142.6.722. PMID: 16785374.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hensen P, Müller ML, Haschemi R, Ständer H, Luger TA, Sunderkötter C, Schiller M. Predisposing factors of actinic keratosis in a North-West German population. Eur J Dermatol. 2009 Jul-Aug; 19 (4): 345–54. DOI: 10.1684/ejd.2009.0706. Epub 2009 May 25. PMID: 19470418.</mixed-citation><mixed-citation xml:lang="en">Hensen P, Müller ML, Haschemi R, Ständer H, Luger TA, Sunderkötter C, Schiller M. Predisposing factors of actinic keratosis in a North-West German population. Eur J Dermatol. 2009 Jul-Aug; 19 (4): 345–54. DOI: 10.1684/ejd.2009.0706. Epub 2009 May 25. PMID: 19470418.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001 Oct; 63 (1–3): 8–18. DOI: 10.1016/s1011–1344(01)00198–1. PMID: 11684447.</mixed-citation><mixed-citation xml:lang="en">Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001 Oct; 63 (1–3): 8–18. DOI: 10.1016/s1011–1344(01)00198–1. PMID: 11684447.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ulrich C, Jürgensen JS, Degen A, Hackethal M, et. al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24-months, prospective, case-control study. Br J Dermatol. 2009 Nov;161 Suppl 3: 78–84. DOI: 10.1111/j.1365–2133.2009.09453.x. PMID: 19775361.</mixed-citation><mixed-citation xml:lang="en">Ulrich C, Jürgensen JS, Degen A, Hackethal M, et. al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24-months, prospective, case-control study. Br J Dermatol. 2009 Nov;161 Suppl 3: 78–84. DOI: 10.1111/j.1365–2133.2009.09453.x. PMID: 19775361.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">O’Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011 Aug; 65 (2): 253–261. DOI: 10.1016/j.jaad.2010.11.062. PMID: 21763561.</mixed-citation><mixed-citation xml:lang="en">O’Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011 Aug; 65 (2): 253–261. DOI: 10.1016/j.jaad.2010.11.062. PMID: 21763561.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nashan D, Meiss F, Müller M. Therapeutic strategies for actinic keratoses – a systematic review. Eur J Dermatol. 2013 Jan-Feb; 23 (1): 14–32. DOI: 10.1684/ejd.2013.1923. PMID: 23477760.</mixed-citation><mixed-citation xml:lang="en">Nashan D, Meiss F, Müller M. Therapeutic strategies for actinic keratoses – a systematic review. Eur J Dermatol. 2013 Jan-Feb; 23 (1): 14–32. DOI: 10.1684/ejd.2013.1923. PMID: 23477760.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002 Jul; 47 (1): 1–17; quiz 18–20. DOI: 10.1067/mjd.2002.125579. PMID: 12077575.</mixed-citation><mixed-citation xml:lang="en">Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002 Jul; 47 (1): 1–17; quiz 18–20. DOI: 10.1067/mjd.2002.125579. PMID: 12077575.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wallingford SC, Russell SA, Vail A, Proby CM, Lear JT, Green AC. Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, UK. Acta Derm Venereol. 2015 Sep; 95 (7): 830–4. DOI: 10.2340/00015555–2098. PMID: 25784002.</mixed-citation><mixed-citation xml:lang="en">Wallingford SC, Russell SA, Vail A, Proby CM, Lear JT, Green AC. Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, UK. Acta Derm Venereol. 2015 Sep; 95 (7): 830–4. DOI: 10.2340/00015555–2098. PMID: 25784002.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yaldiz M. Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic. Medicine (Baltimore). 2019; 98 (28): e16465. DOI: 10.1097/MD.0000000000016465.</mixed-citation><mixed-citation xml:lang="en">Yaldiz M. Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic. Medicine (Baltimore). 2019; 98 (28): e16465. DOI: 10.1097/MD.0000000000016465.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Spencer J. Understanding actinic keratosis: epidemiology, biology, and management of the disease. J Am Acad Dermatol. 2013 Jan; 68 (1 Suppl 1): S 1. DOI: 10.1016/j.jaad.2012.10.006. PMID: 23228300.</mixed-citation><mixed-citation xml:lang="en">Spencer J. Understanding actinic keratosis: epidemiology, biology, and management of the disease. J Am Acad Dermatol. 2013 Jan; 68 (1 Suppl 1): S 1. DOI: 10.1016/j.jaad.2012.10.006. PMID: 23228300.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013 Jan; 68 (1 Suppl 1): S 10–9. DOI: 10.1016/j.jaad.2012.09.053. PMID: 23228301.</mixed-citation><mixed-citation xml:lang="en">Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013 Jan; 68 (1 Suppl 1): S 10–9. DOI: 10.1016/j.jaad.2012.09.053. PMID: 23228301.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Eng W, Cockerell CJ. Effects of ultraviolet irradiation on inflammation in the skin. Adv Dermatol. 2002; 18: 247–86. PMID: 12528408.</mixed-citation><mixed-citation xml:lang="en">Wang L, Eng W, Cockerell CJ. Effects of ultraviolet irradiation on inflammation in the skin. Adv Dermatol. 2002; 18: 247–86. PMID: 12528408.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bowden GT. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer. 2004 Jan; 4 (1): 23–35. DOI: 10.1038/nrc1253. PMID: 14681688.</mixed-citation><mixed-citation xml:lang="en">Bowden GT. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer. 2004 Jan; 4 (1): 23–35. DOI: 10.1038/nrc1253. PMID: 14681688.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rodust PM, Stockfleth E, Ulrich C, Leverkus M, Eberle J. UV-induced squamous cell carcinoma – a role for antiapoptotic signalling pathways. Br J Dermatol. 2009 Nov; 161 Suppl 3: 107–15. DOI: 10.1111/j.1365–2133.2009.09458.x. PMID: 19775366.</mixed-citation><mixed-citation xml:lang="en">Rodust PM, Stockfleth E, Ulrich C, Leverkus M, Eberle J. UV-induced squamous cell carcinoma – a role for antiapoptotic signalling pathways. Br J Dermatol. 2009 Nov; 161 Suppl 3: 107–15. DOI: 10.1111/j.1365–2133.2009.09458.x. PMID: 19775366.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">D’Costa AM, Robinson JK, Maududi T, Chaturvedi V, Nickoloff BJ, Denning MF. The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas. Oncogene. 2006 Jan 19; 25 (3): 378–86. DOI: 10.1038/sj.onc.1209065. PMID: 16158048.</mixed-citation><mixed-citation xml:lang="en">D’Costa AM, Robinson JK, Maududi T, Chaturvedi V, Nickoloff BJ, Denning MF. The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas. Oncogene. 2006 Jan 19; 25 (3): 378–86. DOI: 10.1038/sj.onc.1209065. PMID: 16158048.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Heck DE, Gerecke DR, Vetrano AM, Laskin JD. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol Appl Pharmacol. 2004 Mar 15; 195 (3): 288–97. DOI: 10.1016/j.taap.2003.09.028. PMID: 15020191.</mixed-citation><mixed-citation xml:lang="en">Heck DE, Gerecke DR, Vetrano AM, Laskin JD. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol Appl Pharmacol. 2004 Mar 15; 195 (3): 288–97. DOI: 10.1016/j.taap.2003.09.028. PMID: 15020191.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Васенова В. Ю., Бутов Ю. С., Иванова М. С. Особенности патогенеза, клинической картины и лечения актинического кератоза. Российский журнал кожных и венерических болезней. 2017. № 1. Vasenova V. Yu., Butov Yu.S., Ivanova M. S. Features of the pathogenesis, clinical picture and treatment of actinic keratosis. Russian Journal of Skin and Venereal Diseases. 2017. No. 1.</mixed-citation><mixed-citation xml:lang="en">Vasenova V. Yu., Butov Yu.S., Ivanova M. S. Features of the pathogenesis, clinical picture and treatment of actinic keratosis. Russian Journal of Skin and Venereal Diseases. 2017. No. 1.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Dermoscopy of Melanoma and Non-melanoma Skin Cancers. Front Med (Lausanne). 2019 Aug 21; 6: 180. DOI: 10.3389/fmed.2019.00180. PMID: 31497603; PMCID: PMC 6712997.</mixed-citation><mixed-citation xml:lang="en">Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Dermoscopy of Melanoma and Non-melanoma Skin Cancers. Front Med (Lausanne). 2019 Aug 21; 6: 180. DOI: 10.3389/fmed.2019.00180. PMID: 31497603; PMCID: PMC 6712997.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Peris K, Micantonio T, Piccolo D, Fargnoli MC. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges. 2007 Nov; 5(11): 970–6. English, German. DOI: 10.1111/j.1610–0387.2007.06318.x. Epub 2007 Oct 1. PMID: 17908179.</mixed-citation><mixed-citation xml:lang="en">Peris K, Micantonio T, Piccolo D, Fargnoli MC. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges. 2007 Nov; 5(11): 970–6. English, German. DOI: 10.1111/j.1610–0387.2007.06318.x. Epub 2007 Oct 1. PMID: 17908179.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Abudu B, Calame A, Cohen PR. Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma. Cureus. 2019 May 22; 11 (5): e4721. DOI: 10.7759/cureus.4721. PMID: 31355081; PMCID: PMC 6650181.</mixed-citation><mixed-citation xml:lang="en">Abudu B, Calame A, Cohen PR. Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma. Cureus. 2019 May 22; 11 (5): e4721. DOI: 10.7759/cureus.4721. PMID: 31355081; PMCID: PMC 6650181.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Butani AK, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg. 2005 Apr; 32 (2): 223–35. DOI: 10.1016/j.cps.2004.11.001. Erratum in: Clin Plast Surg. 2006 Jul; 33 (3): 497. PMID: 15814119.</mixed-citation><mixed-citation xml:lang="en">Butani AK, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg. 2005 Apr; 32 (2): 223–35. DOI: 10.1016/j.cps.2004.11.001. Erratum in: Clin Plast Surg. 2006 Jul; 33 (3): 497. PMID: 15814119.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bakshi A, Shafi R, Nelson J, Cantrell WC, Subhadarshani S, Andea A, Athar M, Elmets CA. The clinical course of actinic keratosis correlates with underlying molecular mechanisms. Br J Dermatol. 2020 Apr; 182 (4): 995–1002. DOI: 10.1111/bjd.18338. Epub 2019 Sep 11. PMID: 31299087; PMCID: PMC 7309433.</mixed-citation><mixed-citation xml:lang="en">Bakshi A, Shafi R, Nelson J, Cantrell WC, Subhadarshani S, Andea A, Athar M, Elmets CA. The clinical course of actinic keratosis correlates with underlying molecular mechanisms. Br J Dermatol. 2020 Apr; 182 (4): 995–1002. DOI: 10.1111/bjd.18338. Epub 2019 Sep 11. PMID: 31299087; PMCID: PMC 7309433.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Martín JM, Bella-Navarro R, Jordá E. Vascularización en dermatoscopia [Vascular patterns in dermoscopy]. Actas Dermosifiliogr. 2012 Jun; 103 (5): 357–75. Spanish. DOI: 10.1016/j.ad.2011.11.005. Epub 2012 Mar 29. PMID: 22463770.</mixed-citation><mixed-citation xml:lang="en">Martín JM, Bella-Navarro R, Jordá E. Vascularización en dermatoscopia [Vascular patterns in dermoscopy]. Actas Dermosifiliogr. 2012 Jun; 103 (5): 357–75. Spanish. DOI: 10.1016/j.ad.2011.11.005. Epub 2012 Mar 29. PMID: 22463770.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kittler H, Marghoob AA, Argenziano G, Carrera C, Curiel-Lewandrowski C et. all. Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy. J Am Acad Dermatol. 2016 Jun; 74 (6): 1093–106. DOI: 10.1016/j.jaad.2015.12.038. Epub 2016 Feb 17. PMID: 26896294; PMCID: PMC 5551974.</mixed-citation><mixed-citation xml:lang="en">Kittler H, Marghoob AA, Argenziano G, Carrera C, Curiel-Lewandrowski C et. all. Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy. J Am Acad Dermatol. 2016 Jun; 74 (6): 1093–106. DOI: 10.1016/j.jaad.2015.12.038. Epub 2016 Feb 17. PMID: 26896294; PMCID: PMC 5551974.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Zalaudek I, Giacomel J, Schmid K et, all. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol. 2012 Apr; 66 (4): 589–97. DOI: 10.1016/j.jaad.2011.02.011. Epub 2011 Aug 11. PMID: 21839538.</mixed-citation><mixed-citation xml:lang="en">Zalaudek I, Giacomel J, Schmid K et, all. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. J Am Acad Dermatol. 2012 Apr; 66 (4): 589–97. DOI: 10.1016/j.jaad.2011.02.011. Epub 2011 Aug 11. PMID: 21839538.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Moscarella, E., Rabinovitz, H., Zalaudek, I. et. all. (2014). Dermoscopy and reflectance confocal microscopy of pigmented actinic keratoses: a morphological study. Journal of the European Academy of Dermatology and Venereology, 29 (2), 307–314. DOI: 10.1111/jdv.12532</mixed-citation><mixed-citation xml:lang="en">Moscarella, E., Rabinovitz, H., Zalaudek, I. et. all. (2014). Dermoscopy and reflectance confocal microscopy of pigmented actinic keratoses: a morphological study. Journal of the European Academy of Dermatology and Venereology, 29 (2), 307–314. DOI: 10.1111/jdv.12532</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Casari A, Chester J, Pellacani G. Actinic Keratosis and Non-Invasive Diagnostic Techniques: An Update. Biomedicines. 2018 Jan 8; 6 (1): 8. DOI: 10.3390/biomedicines6010008. PMID: 29316678; PMCID: PMC 5874665.</mixed-citation><mixed-citation xml:lang="en">Casari A, Chester J, Pellacani G. Actinic Keratosis and Non-Invasive Diagnostic Techniques: An Update. Biomedicines. 2018 Jan 8; 6 (1): 8. DOI: 10.3390/biomedicines6010008. PMID: 29316678; PMCID: PMC 5874665.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Werner RN, Jacobs A, Rosumeck S, Erdmann R, Sporbeck B, Nast A. Methods and Results Report – Evidence and consensus-based (S 3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum. J Eur Acad Dermatol Venereol. 2015 Nov; 29 (11): e1–66. DOI: 10.1111/jdv.13179. Epub 2015 Sep 9. PMID: 26350885.</mixed-citation><mixed-citation xml:lang="en">Werner RN, Jacobs A, Rosumeck S, Erdmann R, Sporbeck B, Nast A. Methods and Results Report – Evidence and consensus-based (S 3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum. J Eur Acad Dermatol Venereol. 2015 Nov; 29 (11): e1–66. DOI: 10.1111/jdv.13179. Epub 2015 Sep 9. PMID: 26350885.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Vieira RA, Minicucci EM, Marques ME, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol. 2012 Jan-Feb; 87 (1): 105–14. DOI: 10.1590/s0365–05962012000100013. PMID: 22481658.</mixed-citation><mixed-citation xml:lang="en">Vieira RA, Minicucci EM, Marques ME, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol. 2012 Jan-Feb; 87 (1): 105–14. DOI: 10.1590/s0365–05962012000100013. PMID: 22481658.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Nascimento MM, Shitara D, Enokihara MM et. All. Inner gray halo, a novel dermoscopic feature for the diagnosis of pigmented actinic keratosis: clues for the differential diagnosis with lentigo maligna. J Am Acad Dermatol. 2014 Oct; 71 (4): 708–15. DOI: 10.1016/j.jaad.2014.05.025. Epub 2014 Jun 17. PMID: 24947988.</mixed-citation><mixed-citation xml:lang="en">Nascimento MM, Shitara D, Enokihara MM et. All. Inner gray halo, a novel dermoscopic feature for the diagnosis of pigmented actinic keratosis: clues for the differential diagnosis with lentigo maligna. J Am Acad Dermatol. 2014 Oct; 71 (4): 708–15. DOI: 10.1016/j.jaad.2014.05.025. Epub 2014 Jun 17. PMID: 24947988.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Lallas A, Argenziano G, Moscarella E, Longo C, Simonetti V, Zalaudek I. Diagnosis and management of facial pigmented macules. Clin Dermatol. 2014 Jan-Feb; 32 (1): 94–100. DOI: 10.1016/j.clindermatol.2013.05.030. PMID: 24314382.</mixed-citation><mixed-citation xml:lang="en">Lallas A, Argenziano G, Moscarella E, Longo C, Simonetti V, Zalaudek I. Diagnosis and management of facial pigmented macules. Clin Dermatol. 2014 Jan-Feb; 32 (1): 94–100. DOI: 10.1016/j.clindermatol.2013.05.030. PMID: 24314382.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Chong A. H., Sinclair R. Actinic Keratoses. In: Treatment of Skin Disease. Comprehensive therapeutic strategies 2nd Ed. by M. G. Lebwohl, W. R. Haymann et al. Mosby, 2006: 14–16.</mixed-citation><mixed-citation xml:lang="en">Chong A. H., Sinclair R. Actinic Keratoses. In: Treatment of Skin Disease. Comprehensive therapeutic strategies 2nd Ed. by M. G. Lebwohl, W. R. Haymann et al. Mosby, 2006: 14–16.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">В. А. Молочков, Ю. В. Молочкова. Дерматоонкология: лечение. Практическая медицина. Москва. 2018, с. 224. V. A. Molochkov, Yu. V. Molochkova. Dermato-oncology: treatment. Practical medicine. Moscow. 2018, p. 224.</mixed-citation><mixed-citation xml:lang="en">V. A. Molochkov, Yu. V. Molochkova. Dermato-oncology: treatment. Practical medicine. Moscow. 2018, p. 224.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer. 2009 Jun 1; 115 (11): 2523–30. DOI: 10.1002/cncr.24284. PMID: 19382202.</mixed-citation><mixed-citation xml:lang="en">Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer. 2009 Jun 1; 115 (11): 2523–30. DOI: 10.1002/cncr.24284. PMID: 19382202.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013 Sep; 169 (3): 502–18. DOI: 10.1111/bjd.12420. PMID: 23647091.</mixed-citation><mixed-citation xml:lang="en">Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013 Sep; 169 (3): 502–18. DOI: 10.1111/bjd.12420. PMID: 23647091.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Beatson M, Siegel JA, Chren MM, Weinstock MA. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial. Eur J Dermatol. 2019 Oct 1; 29 (5): 507–510. DOI: 10.1684/ejd.2019.3637. PMID: 31647464.</mixed-citation><mixed-citation xml:lang="en">Beatson M, Siegel JA, Chren MM, Weinstock MA. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial. Eur J Dermatol. 2019 Oct 1; 29 (5): 507–510. DOI: 10.1684/ejd.2019.3637. PMID: 31647464.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009 Aug; 26 (3): 150–63. DOI: 10.1053/j.semdp.2009.09.003. PMID: 20043514.</mixed-citation><mixed-citation xml:lang="en">Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009 Aug; 26 (3): 150–63. DOI: 10.1053/j.semdp.2009.09.003. PMID: 20043514.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Hutchinson J. A. Morbid growths and tumors: the crateriform ulcer of the face, a form of acute epithelial cancer. Trans Pathol Soc London. 1889; 40: 275–281.</mixed-citation><mixed-citation xml:lang="en">Hutchinson J. A. Morbid growths and tumors: the crateriform ulcer of the face, a form of acute epithelial cancer. Trans Pathol Soc London. 1889; 40: 275–281.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Choonhakarn, Charoen &amp; Ackerman, A. B. Keratoacanthomas: A new classification based on morphologic findings and on anatomic site. Dermatopathol Pract Concept. 7. 2001. 7–16.</mixed-citation><mixed-citation xml:lang="en">Choonhakarn, Charoen &amp; Ackerman, A. B. Keratoacanthomas: A new classification based on morphologic findings and on anatomic site. Dermatopathol Pract Concept. 7. 2001. 7–16.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Dupont A: Kystes sébacés végétans, kératoacanthomes, verrucomes. Bull Soc Fr Dermatolol Syphiligr 59: 340, 1952. 5.</mixed-citation><mixed-citation xml:lang="en">Dupont A: Kystes sébacés végétans, kératoacanthomes, verrucomes. Bull Soc Fr Dermatolol Syphiligr 59: 340, 1952. 5.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">MacCormac H, Scarff RW: Molluscum sebaceum. Br J Dermatol 1936; 48: 624–6276.</mixed-citation><mixed-citation xml:lang="en">MacCormac H, Scarff RW: Molluscum sebaceum. Br J Dermatol 1936; 48: 624–6276.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Halnan K. E. Molluscum pseudocarcinomatosum. Lancet. 1953 Dec 26; 265 (6800): 1358. DOI: 10.1016/s0140–6736(53)91287–2. PMID: 13110177.</mixed-citation><mixed-citation xml:lang="en">Halnan K. E. Molluscum pseudocarcinomatosum. Lancet. 1953 Dec 26; 265 (6800): 1358. DOI: 10.1016/s0140–6736(53)91287–2. PMID: 13110177.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Rook A.J, Whimster I.W: Le kératoacanthome. Arch Belg Dermatol Syph 6: 137–146, 1950.</mixed-citation><mixed-citation xml:lang="en">Rook A.J, Whimster I.W: Le kératoacanthome. Arch Belg Dermatol Syph 6: 137–146, 1950.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Rook A.J, Whimster I.W: Keratoacanthoma – A thirty-year retrospect. Br J Dermatol 100: 41–47, 1979.</mixed-citation><mixed-citation xml:lang="en">Rook A.J, Whimster I.W: Keratoacanthoma – A thirty-year retrospect. Br J Dermatol 100: 41–47, 1979.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Karaa A, Khachemoune A. Keratoacanthoma: a tumor in search of a classification. Int J Dermatol. 2007 Jul; 46 (7): 671–8. DOI: 10.1111/j.1365–4632.2007.03260.x. PMID: 17614793.</mixed-citation><mixed-citation xml:lang="en">Karaa A, Khachemoune A. Keratoacanthoma: a tumor in search of a classification. Int J Dermatol. 2007 Jul; 46 (7): 671–8. DOI: 10.1111/j.1365–4632.2007.03260.x. PMID: 17614793.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Zito PM, Scharf R. Keratoacanthoma. [Updated 2020 Aug 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.</mixed-citation><mixed-citation xml:lang="en">Zito PM, Scharf R. Keratoacanthoma. [Updated 2020 Aug 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Majores M, Bierhoff E. Aktinische Keratose, Morbus Bowen, Keratoakanthom und Plattenepithelkarzinom der Haut [Actinic keratosis, Bowen’s disease, keratoacanthoma and squamous cell carcinoma of the skin]. Pathologe. 2015 Feb; 36 (1): 16–29. German. DOI: 10.1007/s00292–014–2063–3. PMID: 25663185.</mixed-citation><mixed-citation xml:lang="en">Majores M, Bierhoff E. Aktinische Keratose, Morbus Bowen, Keratoakanthom und Plattenepithelkarzinom der Haut [Actinic keratosis, Bowen’s disease, keratoacanthoma and squamous cell carcinoma of the skin]. Pathologe. 2015 Feb; 36 (1): 16–29. German. DOI: 10.1007/s00292–014–2063–3. PMID: 25663185.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Kwiek B, Schwartz RA. Keratoacanthoma (KA): An update and review. J Am Acad Dermatol. 2016 Jun; 74 (6): 1220–33. DOI: 10.1016/j.jaad.2015.11.033. Epub 2016 Feb 4. PMID: 26853179.</mixed-citation><mixed-citation xml:lang="en">Kwiek B, Schwartz RA. Keratoacanthoma (KA): An update and review. J Am Acad Dermatol. 2016 Jun; 74 (6): 1220–33. DOI: 10.1016/j.jaad.2015.11.033. Epub 2016 Feb 4. PMID: 26853179.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Quinn Adam, et al. Eruptive keratoacanthomas in tattoos. Australasian Journal of Dermatology 58.4 (2017): 317–318.</mixed-citation><mixed-citation xml:lang="en">Quinn Adam, et al. Eruptive keratoacanthomas in tattoos. Australasian Journal of Dermatology 58.4 (2017): 317–318.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Богомолова И. А., Антонеева И. И., Долгова Д. Р. Клинические особенности течения колоректального рака у пациентов с мутациями генов EGFR-сигнального пути. Ульяновский медико-биологический журнал. 2019. № 1. Bogomolova I. A., Antoneeva I. I., Dolgova D. R. Clinical features of the course of colorectal cancer in patients with mutations in the EGFR signaling pathway genes. Ulyanovsk Medical and Biological Journal. 2019. No. 1.</mixed-citation><mixed-citation xml:lang="en">Bogomolova I. A., Antoneeva I. I., Dolgova D. R. Clinical features of the course of colorectal cancer in patients with mutations in the EGFR signaling pathway genes. Ulyanovsk Medical and Biological Journal. 2019. No. 1.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Cristalli MP, Marini R, LA Monaca G, Vitolo D, Pompa G, Annibali S. Double localization of keratoacantho-ma on the cutaneous and mucosal sides of the lower lip: report of a case. Oral Implantol (Rome). 2014 May 19; 6 (4): 94–8. PMID: 24971163; PMCID: PMC 4051273.</mixed-citation><mixed-citation xml:lang="en">Cristalli MP, Marini R, LA Monaca G, Vitolo D, Pompa G, Annibali S. Double localization of keratoacantho-ma on the cutaneous and mucosal sides of the lower lip: report of a case. Oral Implantol (Rome). 2014 May 19; 6 (4): 94–8. PMID: 24971163; PMCID: PMC 4051273.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Lin MJ, Pan Y, Jalilian C, Kelly JW. Dermoscopic characteristics of nodular squamous cell carcinoma and keratoacanthoma. Dermatol Pract Concept. 2014 Apr 30; 4 (2): 9–15. DOI: 10.5826/dpc.0402a02. PMID: 24855567; PMCID: PMC 4029247.</mixed-citation><mixed-citation xml:lang="en">Lin MJ, Pan Y, Jalilian C, Kelly JW. Dermoscopic characteristics of nodular squamous cell carcinoma and keratoacanthoma. Dermatol Pract Concept. 2014 Apr 30; 4 (2): 9–15. DOI: 10.5826/dpc.0402a02. PMID: 24855567; PMCID: PMC 4029247.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Higgins JC, Maher MH, Douglas MS. Diagnosing Common Benign Skin Tumors. Am Fam Physician. 2015 Oct 1; 92 (7): 601–7. PMID: 26447443.</mixed-citation><mixed-citation xml:lang="en">Higgins JC, Maher MH, Douglas MS. Diagnosing Common Benign Skin Tumors. Am Fam Physician. 2015 Oct 1; 92 (7): 601–7. PMID: 26447443.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Bedir R, Güçer H, Şehitoğlu İ, et all. The Role of p16, p21, p27, p53 and Ki‑67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study. Balkan Med J. 2016 Mar; 33 (2): 121–7. DOI: 10.5152/balkanmedj.2016.16442. Epub 2016 Mar 1. PMID: 27403379; PMCID: PMC 4924954.</mixed-citation><mixed-citation xml:lang="en">Bedir R, Güçer H, Şehitoğlu İ, et all. The Role of p16, p21, p27, p53 and Ki‑67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study. Balkan Med J. 2016 Mar; 33 (2): 121–7. DOI: 10.5152/balkanmedj.2016.16442. Epub 2016 Mar 1. PMID: 27403379; PMCID: PMC 4924954.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Chaser BE, Renszel KM, Crowson AN et. All. Onycholemmal carcinoma: a morphologic comparison of 6 reported cases. J Am Acad Dermatol. 2013 Feb; 68 (2): 290–5. DOI: 10.1016/j.jaad.2012.07.015. Epub 2012 Aug 20. PMID: 22917894.</mixed-citation><mixed-citation xml:lang="en">Chaser BE, Renszel KM, Crowson AN et. All. Onycholemmal carcinoma: a morphologic comparison of 6 reported cases. J Am Acad Dermatol. 2013 Feb; 68 (2): 290–5. DOI: 10.1016/j.jaad.2012.07.015. Epub 2012 Aug 20. PMID: 22917894.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">LaPresto L, Cranmer L, Morrison L, et. All. A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil. JAMA Dermatol. 2013 Mar; 149 (3): 279–81. DOI: 10.1001/jamadermatol.2013.2583. PMID: 23552479; PMCID: PMC 4575122.</mixed-citation><mixed-citation xml:lang="en">LaPresto L, Cranmer L, Morrison L, et. All. A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil. JAMA Dermatol. 2013 Mar; 149 (3): 279–81. DOI: 10.1001/jamadermatol.2013.2583. PMID: 23552479; PMCID: PMC 4575122.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Carr RA, Taibjee SM, Turnbull N, Attili S. Follicular squamous cell carcinoma is an under-recognized common skin tumor. Diag Histopathol. 2014; 20: 289–296.</mixed-citation><mixed-citation xml:lang="en">Carr RA, Taibjee SM, Turnbull N, Attili S. Follicular squamous cell carcinoma is an under-recognized common skin tumor. Diag Histopathol. 2014; 20: 289–296.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Griffiths RW. Keratoacanthoma observed. Br J Plast Surg. 2004 Sep; 57 (6): 485–501. DOI: 10.1016/j.bjps.2004.05.007. PMID: 15308394.</mixed-citation><mixed-citation xml:lang="en">Griffiths RW. Keratoacanthoma observed. Br J Plast Surg. 2004 Sep; 57 (6): 485–501. DOI: 10.1016/j.bjps.2004.05.007. PMID: 15308394.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Hu SC, Chiu HH, Chen GS, Ke CL, Cheng ST. Dermoscopy as a diagnostic and follow-up tool for pigmented Bowen’s disease on acral region. Dermatol Surg. 2008 Sep; 34 (9): 1248–53; discussion 1253. DOI: 10.1111/j.1524–4725.2008.34269.x. Epub 2008 Jun 12. PMID: 18554290.</mixed-citation><mixed-citation xml:lang="en">Hu SC, Chiu HH, Chen GS, Ke CL, Cheng ST. Dermoscopy as a diagnostic and follow-up tool for pigmented Bowen’s disease on acral region. Dermatol Surg. 2008 Sep; 34 (9): 1248–53; discussion 1253. DOI: 10.1111/j.1524–4725.2008.34269.x. Epub 2008 Jun 12. PMID: 18554290.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Lee M. M., &amp; Wick M. M. (1990). Bowen’s disease. CA: A Cancer Journal for Clinicians, 40 (4), 237–242. DOI: 10.3322/canjclin.40.4.237.</mixed-citation><mixed-citation xml:lang="en">Lee M. M., &amp; Wick M. M. (1990). Bowen’s disease. CA: A Cancer Journal for Clinicians, 40 (4), 237–242. DOI: 10.3322/canjclin.40.4.237.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Lee M. M., &amp; Wick M. M. (1993). Bowen’s disease. Clinics in Dermatology, 11 (1), 43–46.</mixed-citation><mixed-citation xml:lang="en">Lee M. M., &amp; Wick M. M. (1993). Bowen’s disease. Clinics in Dermatology, 11 (1), 43–46.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Bath-Hextall F.J., Matin R. N., Wilkinson D., &amp; Leonardi-Bee J. (2013). Interventions for cutaneous Bowen’s disease. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.cd007281.pub2.</mixed-citation><mixed-citation xml:lang="en">Bath-Hextall F.J., Matin R. N., Wilkinson D., &amp; Leonardi-Bee J. (2013). Interventions for cutaneous Bowen’s disease. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.cd007281.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Shimizu A, Tamura A, Abe M, Amano H, Motegi S, Nakatani Y, Hoshino H, Ishikawa O. Human papillomavirus type 56-associated Bowen disease. Br J Dermatol. 2012 Nov; 167 (5): 1161–4. DOI: 10.1111/j.1365–2133.2012.11071.x. PMID: 22630056.</mixed-citation><mixed-citation xml:lang="en">Shimizu A, Tamura A, Abe M, Amano H, Motegi S, Nakatani Y, Hoshino H, Ishikawa O. Human papillomavirus type 56-associated Bowen disease. Br J Dermatol. 2012 Nov; 167 (5): 1161–4. DOI: 10.1111/j.1365–2133.2012.11071.x. PMID: 22630056.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Cox NH, Eedy DJ, Morton CA; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen’s disease: 2006 update. Br J Dermatol. 2007 Jan; 156 (1): 11–21. DOI: 10.1111/j.1365–2133.2006.07610.x. PMID: 17199561.</mixed-citation><mixed-citation xml:lang="en">Cox NH, Eedy DJ, Morton CA; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen’s disease: 2006 update. Br J Dermatol. 2007 Jan; 156 (1): 11–21. DOI: 10.1111/j.1365–2133.2006.07610.x. PMID: 17199561.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Lee CH, Yu HS. Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis. Front Biosci (Schol Ed). 2016 Jun 1; 8: 312–20. DOI: 10.2741/s465. PMID: 27100709.</mixed-citation><mixed-citation xml:lang="en">Lee CH, Yu HS. Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis. Front Biosci (Schol Ed). 2016 Jun 1; 8: 312–20. DOI: 10.2741/s465. PMID: 27100709.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Lallas A, Argenziano G, Zendri E, et.all. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev Anticancer Ther. 2013 May; 13 (5): 541–58. DOI: 10.1586/era.13.38. PMID: 23617346.</mixed-citation><mixed-citation xml:lang="en">Lallas A, Argenziano G, Zendri E, et.all. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev Anticancer Ther. 2013 May; 13 (5): 541–58. DOI: 10.1586/era.13.38. PMID: 23617346.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Baker BA, Cassano VA, Murray C; ACOEM Task Force on Arsenic Exposure. Arsenic Exposure, Assessment, Toxicity, Diagnosis, and Management: Guidance for Occupational and Environmental Physicians. J Occup Environ Med. 2018 Dec; 60 (12): e634–e639. DOI: 10.1097/JOM.0000000000001485. PMID: 30358658.</mixed-citation><mixed-citation xml:lang="en">Baker BA, Cassano VA, Murray C; ACOEM Task Force on Arsenic Exposure. Arsenic Exposure, Assessment, Toxicity, Diagnosis, and Management: Guidance for Occupational and Environmental Physicians. J Occup Environ Med. 2018 Dec; 60 (12): e634–e639. DOI: 10.1097/JOM.0000000000001485. PMID: 30358658.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Hsueh YM, Huang YL, Huang CC et. all. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A. 1998 Jul 24; 54 (6): 431–44. DOI: 10.1080/009841098158728. PMID: 9661909.</mixed-citation><mixed-citation xml:lang="en">Hsueh YM, Huang YL, Huang CC et. all. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A. 1998 Jul 24; 54 (6): 431–44. DOI: 10.1080/009841098158728. PMID: 9661909.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Huang YK, Huang YL, Hsueh YM et. All. Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan. Environ Health Perspect. 2009 Dec; 117 (12): 1860–6. DOI: 10.1289/ehp.0900560. Epub 2009 Jul 29. PMID: 20049204; PMCID: PMC 2799459.</mixed-citation><mixed-citation xml:lang="en">Huang YK, Huang YL, Hsueh YM et. All. Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan. Environ Health Perspect. 2009 Dec; 117 (12): 1860–6. DOI: 10.1289/ehp.0900560. Epub 2009 Jul 29. PMID: 20049204; PMCID: PMC 2799459.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Chanda S, Dasgupta UB, Guhamazumder D et. All. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006 Feb; 89 (2): 431–7. DOI: 10.1093/toxsci/kfj030. Epub 2005 Oct 26. PMID: 16251483.</mixed-citation><mixed-citation xml:lang="en">Chanda S, Dasgupta UB, Guhamazumder D et. All. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006 Feb; 89 (2): 431–7. DOI: 10.1093/toxsci/kfj030. Epub 2005 Oct 26. PMID: 16251483.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou X, Sun H, Ellen TP et.all. Arsenite alters global histone H3 methylation. Carcinogenesis. 2008 Sep; 29 (9): 1831–6. DOI: 10.1093/carcin/bgn063. Epub 2008 Mar 4. PMID: 18321869; PMCID: PMC 2722848.</mixed-citation><mixed-citation xml:lang="en">Zhou X, Sun H, Ellen TP et.all. Arsenite alters global histone H3 methylation. Carcinogenesis. 2008 Sep; 29 (9): 1831–6. DOI: 10.1093/carcin/bgn063. Epub 2008 Mar 4. PMID: 18321869; PMCID: PMC 2722848.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Ribero S, Mangino M, Bataille V. Skin phenotypes can offer some insight about the association between telomere length and cancer susceptibility. Med Hypotheses. 2016 Dec; 97: 7–10. DOI: 10.1016/j.mehy.2016.10.010. Epub 2016 Oct 19. PMID: 27876133.</mixed-citation><mixed-citation xml:lang="en">Ribero S, Mangino M, Bataille V. Skin phenotypes can offer some insight about the association between telomere length and cancer susceptibility. Med Hypotheses. 2016 Dec; 97: 7–10. DOI: 10.1016/j.mehy.2016.10.010. Epub 2016 Oct 19. PMID: 27876133.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada-Hishida H, Nobeyama Y, Nakagawa H. Correlation of telomere length to malignancy potential in non-melanoma skin cancers. Oncol Lett. 2018 Jan; 15 (1): 393–399. DOI: 10.3892/ol.2017.7278. Epub 2017 Oct 26. PMID: 29285197; PMCID: PMC 5738687.</mixed-citation><mixed-citation xml:lang="en">Yamada-Hishida H, Nobeyama Y, Nakagawa H. Correlation of telomere length to malignancy potential in non-melanoma skin cancers. Oncol Lett. 2018 Jan; 15 (1): 393–399. DOI: 10.3892/ol.2017.7278. Epub 2017 Oct 26. PMID: 29285197; PMCID: PMC 5738687.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Lee C.-H., Wu S.-B., Hong, et. al. (2013). Involvement of mtDNA Damage Elicited by Oxidative Stress in the Arsenical Skin Cancers. Journal of Investigative Dermatology, 133 (7), 1890–1900. DOI: 10.1038/jid.2013.55.</mixed-citation><mixed-citation xml:lang="en">Lee C.-H., Wu S.-B., Hong, et. al. (2013). Involvement of mtDNA Damage Elicited by Oxidative Stress in the Arsenical Skin Cancers. Journal of Investigative Dermatology, 133 (7), 1890–1900. DOI: 10.1038/jid.2013.55.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Lee CH, Wu SB, Hong CH, et al. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol. 2011 May; 178 (5): 2066–76. DOI: 10.1016/j.ajpath.2011.01.056. PMID: 21514422; PMCID: PMC 3081159.</mixed-citation><mixed-citation xml:lang="en">Lee CH, Wu SB, Hong CH, et al. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol. 2011 May; 178 (5): 2066–76. DOI: 10.1016/j.ajpath.2011.01.056. PMID: 21514422; PMCID: PMC 3081159.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Samper E, Morgado L, Estrada JC, et al. Increase in mitochondrial biogenesis, oxidative stress, and glycolysis in murine lymphomas. Free Radic Biol Med. 2009 Feb 1; 46 (3): 387–96. DOI: 10.1016/j.freeradbiomed.2008.10.036. Epub 2008 Oct 30. PMID: 19038329; PMCID: PMC 2665299.</mixed-citation><mixed-citation xml:lang="en">Samper E, Morgado L, Estrada JC, et al. Increase in mitochondrial biogenesis, oxidative stress, and glycolysis in murine lymphomas. Free Radic Biol Med. 2009 Feb 1; 46 (3): 387–96. DOI: 10.1016/j.freeradbiomed.2008.10.036. Epub 2008 Oct 30. PMID: 19038329; PMCID: PMC 2665299.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Wen G, Calaf GM, Partridge MA et al. Neoplastic transformation of human small airway epithelial cells induced by arsenic. Mol Med. 2008 Jan-Feb; 14 (1–2): 2–10. DOI: 10.2119/2007–00090.Wen. PMID: 18037969; PMCID: PMC 2082132.</mixed-citation><mixed-citation xml:lang="en">Wen G, Calaf GM, Partridge MA et al. Neoplastic transformation of human small airway epithelial cells induced by arsenic. Mol Med. 2008 Jan-Feb; 14 (1–2): 2–10. DOI: 10.2119/2007–00090.Wen. PMID: 18037969; PMCID: PMC 2082132.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Dang CV. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med. 2013 Aug 1; 3 (8): a014217. DOI: 10.1101/cshperspect.a014217. PMID: 23906881; PMCID: PMC 3721271.</mixed-citation><mixed-citation xml:lang="en">Dang CV. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med. 2013 Aug 1; 3 (8): a014217. DOI: 10.1101/cshperspect.a014217. PMID: 23906881; PMCID: PMC 3721271.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">C. H. Ussakli, A. Ebaee, J. Binkley, et al: Mitochondria and tumor progression in ulcerative colitis. J Natl Cancer Inst, 105 (16), 1239–48 (2013).</mixed-citation><mixed-citation xml:lang="en">C. H. Ussakli, A. Ebaee, J. Binkley, et al: Mitochondria and tumor progression in ulcerative colitis. J Natl Cancer Inst, 105 (16), 1239–48 (2013).</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrándiz, C., Malvehy, J., Guillén, C., Ferrándiz-Pulido, C., &amp; Fernández-Figueras, M. (2017). Precáncer cutáneo. Actas Dermo-Sifiliográficas, 108 (1), 31–41. DOI: 10.1016/j.ad.2016.07.016.</mixed-citation><mixed-citation xml:lang="en">Ferrándiz, C., Malvehy, J., Guillén, C., Ferrándiz-Pulido, C., &amp; Fernández-Figueras, M. (2017). Precáncer cutáneo. Actas Dermo-Sifiliográficas, 108 (1), 31–41. DOI: 10.1016/j.ad.2016.07.016.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Lallas A, Argenziano G, Zendri E et. All. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev Anticancer Ther. 2013 May; 13 (5): 541–58. DOI: 10.1586/era.13.38. PMID: 23617346.</mixed-citation><mixed-citation xml:lang="en">Lallas A, Argenziano G, Zendri E et. All. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Expert Rev Anticancer Ther. 2013 May; 13 (5): 541–58. DOI: 10.1586/era.13.38. PMID: 23617346.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Stamm AW, Kobashi KC, Stefanovic KB. Urologic Dermatology: A Review. Curr Urol Rep. 2017 Aug; 18 (8): 62. DOI: 10.1007/s11934–017–0712–9. PMID: 28667573.</mixed-citation><mixed-citation xml:lang="en">Stamm AW, Kobashi KC, Stefanovic KB. Urologic Dermatology: A Review. Curr Urol Rep. 2017 Aug; 18 (8): 62. DOI: 10.1007/s11934–017–0712–9. PMID: 28667573.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Payapvipapong K, Tanaka M. Dermoscopic classification of Bowen’s disease. Australas J Dermatol. 2015 Feb; 56 (1): 32–5. DOI: 10.1111/ajd.12200. Epub 2014 Oct 21. PMID: 25330999.</mixed-citation><mixed-citation xml:lang="en">Payapvipapong K, Tanaka M. Dermoscopic classification of Bowen’s disease. Australas J Dermatol. 2015 Feb; 56 (1): 32–5. DOI: 10.1111/ajd.12200. Epub 2014 Oct 21. PMID: 25330999.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Dermoscopy of Melanoma and Non-melanoma Skin Cancers. Front Med (Lausanne). 2019 Aug 21; 6: 180. DOI: 10.3389/fmed.2019.00180. PMID: 31497603; PMCID: PMC 6712997.</mixed-citation><mixed-citation xml:lang="en">Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Dermoscopy of Melanoma and Non-melanoma Skin Cancers. Front Med (Lausanne). 2019 Aug 21; 6: 180. DOI: 10.3389/fmed.2019.00180. PMID: 31497603; PMCID: PMC 6712997.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Paolino G, Donati M, Didona D, Mercuri SR, Cantisani C. Histology of Non-Melanoma Skin Cancers: An Update. Biomedicines. 2017 Dec 20; 5 (4): 71. DOI: 10.3390/biomedicines5040071. PMID: 29261131; PMCID: PMC 5744095.</mixed-citation><mixed-citation xml:lang="en">Paolino G, Donati M, Didona D, Mercuri SR, Cantisani C. Histology of Non-Melanoma Skin Cancers: An Update. Biomedicines. 2017 Dec 20; 5 (4): 71. DOI: 10.3390/biomedicines5040071. PMID: 29261131; PMCID: PMC 5744095.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">В. Г. Никитаев, О. Б. Тамразова, А. Н. Проничев, В. Ю. Сергеев, Е. А. Дружинина. Алгоритм анализа характеристик пигментной сети в диагностике меланомы. Матем. моделирование, 33: 2 (2021), 67–81. V. G. Nikitaev, O. B. Tamrazova, A. N. Pronichev, V. Yu. Sergeev, E. A. Druzhinin. Algorithm for analyzing the characteristics of the pigment network in the diagnosis of melanoma. Mat. Modeling, 33: 2 (2021), 67–81.</mixed-citation><mixed-citation xml:lang="en">V. G. Nikitaev, O. B. Tamrazova, A. N. Pronichev, V. Yu. Sergeev, E. A. Druzhinin. Algorithm for analyzing the characteristics of the pigment network in the diagnosis of melanoma. Mat. Modeling, 33: 2 (2021), 67–81.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">В. Г. Никитаев, А. Н. Проничев, О. Б. Тамразова, В. Ю. Сергеев, О. А. Медведева, М. А. Соломатин. Визуализация изображений новообразований кожи для экспертных систем диагностики меланомы. Приборы. 2021; 2: 41–45. V. G. Nikitaev, A. N. Pronichev, O. B. Tamrazova, V. Yu. Sergeev, O. A. Medvedeva, M. A. Solomatin. Visualization of images of skin neoplasms for expert systems for the diagnosis of melanoma. Devices. 2021; 2: 41–45.</mixed-citation><mixed-citation xml:lang="en">V. G. Nikitaev, A. N. Pronichev, O. B. Tamrazova, V. Yu. Sergeev, O. A. Medvedeva, M. A. Solomatin. Visualization of images of skin neoplasms for expert systems for the diagnosis of melanoma. Devices. 2021; 2: 41–45.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
